A Study of MFA-370 in Patients with Metastatic Urothelial Cancer

NCT05390645 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The sponsor company was liquidated.

Conditions

Metastatic Urothelial Cancer

Interventions

DRUG: MFA-370

Sponsor

Ectin Research AB